Mitogen-activated protein kinase kinase kinase 7–TAK1-binding protein 1 complex (MAP3K7–TAB1 complex (or TAK1–TAB1 complex))

The Mitogen-activated protein kinase kinase kinase 7–TAK1-binding protein 1 complex is a key multiprotein signaling module essential for mediating cellular responses to a variety of inflammatory and stress stimuli. TAK1 (MAP3K7) is a serine/threonine protein kinase activated by binding to TAB1, along with other regulatory subunits such as TAB2 or TAB3. Upon formation, this complex mediates phosphorylation cascades that activate downstream kinases (JNK, p38 MAPK) and transcription factors (NF-κB), thereby orchestrating gene expression responses related to inflammation, immunity, cell survival, and apoptosis. The complex is activated by stimuli such as cytokines (e.g., TGF-beta, IL-1, TNF) and toll-like receptor agonists, playing a central role in diseases involving immune dysregulation, chronic inflammation, and cancer[1][3]. Selective inhibitors targeting this complex, particularly TAK1 kinase activity, are under investigation for treating autoimmune disorders and inflammatory diseases[1][3].

Other names

TAK1–TAB1 complexMAP3K7–TAB1 complexMAP3K7–interacting protein complexTAK1 complex

Inhibition of TAK1 kinase activity: Blocks phosphorylation and activation of downstream effectors (e.g., NF-κB, JNK, p38 MAPK), leading to reduced production of inflammatory cytokines like TNF-α; Disruption of protein–protein interactions: Prevents assembly and activation of the TAK1–TAB1 signaling complex